GlassScriptPhysician profile
Muhammad Yasin
NPI 1417309998
$18,458.17
in general payments reported to CMS, 2019-2025
25 companies · $5,194 in 2025
The $5,194 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $210 · 2023: $12K · 2024: $1,242 · 2025: $5,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $7,205 · Education: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,541.95 |
| Food and Beverage | $7,204.50 |
| Education | $501.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,928.93 | 2023-2025 | Optis, Amplatzer Amulet, Amplatzer Torqvue 45 X 45 |
| Edwards Lifesciences Corporation | $3,150.93 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $2,642.99 | 2022-2025 | Turbohawk, Corevalve Evolut R, In.Pact Admiral |
| Angiodynamics, INC. | $2,309.55 | 2023 | Angiovac, Alphavac |
| W. L. Gore & Associates, INC. | $2,251.61 | 2023 | Gore Cardioform Septal Occluder |
| Terumo Medical Corporation | $1,562.43 | 2023 | Glidewire, Glidesheath Slender |
| Abiomed | $385.96 | 2023-2025 | Impella |
| Shockwave Medical, INC | $338.54 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $304.44 | 2023 | Opticross, Avvigo Guidance System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.17 | 2022-2025 | Jardiance |
| Amgen INC. | $207.46 | 2023-2025 | Repatha, Repatha |
| Pfizer INC. | $195.23 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $177.86 | 2025 | Uptravi, Opsumit, Opsynvi |
| Inari Medical, INC. | $171.59 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $139.96 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $136.29 | 2022-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $125.50 | 2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $55.65 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $32.77 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $31.27 | 2025 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.49 | 2024 | Lifevest |
| Tactile Systems Technology INC | $18.79 | 2025 | Nimbl, Flexitouch Plus |
| Scpharmaceuticals INC. | $16.41 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2025 | |
| Merck Sharp & Dohme LLC | $14.00 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Yasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.